These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12105259)

  • 1. Expression of the slit-diaphragm protein, nephrin, in experimental diabetic nephropathy: differing effects of anti-proteinuric therapies.
    Kelly DJ; Aaltonen P; Cox AJ; Rumble JR; Langham R; Panagiotopoulos S; Jerums G; Holthöfer H; Gilbert RE
    Nephrol Dial Transplant; 2002 Jul; 17(7):1327-32. PubMed ID: 12105259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteinuria and the expression of the podocyte slit diaphragm protein, nephrin, in diabetic nephropathy: effects of angiotensin converting enzyme inhibition.
    Langham RG; Kelly DJ; Cox AJ; Thomson NM; Holthöfer H; Zaoui P; Pinel N; Cordonnier DJ; Gilbert RE
    Diabetologia; 2002 Nov; 45(11):1572-6. PubMed ID: 12436341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of nephrin in renal disease including diabetic nephropathy.
    Cooper ME; Mundel P; Boner G
    Semin Nephrol; 2002 Sep; 22(5):393-8. PubMed ID: 12224046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE inhibitors improve nephrin expression in Zucker rats with glomerulosclerosis.
    Blanco S; Bonet J; López D; Casas I; Romero R
    Kidney Int Suppl; 2005 Jan; (93):S10-4. PubMed ID: 15613060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superior renoprotective effects of combination therapy with ACE and AGE inhibition in the diabetic spontaneously hypertensive rat.
    Davis BJ; Forbes JM; Thomas MC; Jerums G; Burns WC; Kawachi H; Allen TJ; Cooper ME
    Diabetologia; 2004 Jan; 47(1):89-97. PubMed ID: 14647892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy.
    Benigni A; Gagliardini E; Tomasoni S; Abbate M; Ruggenenti P; Kalluri R; Remuzzi G
    Kidney Int; 2004 Jun; 65(6):2193-200. PubMed ID: 15149332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases.
    McLennan SV; Kelly DJ; Cox AJ; Cao Z; Lyons JG; Yue DK; Gilbert RE
    Diabetologia; 2002 Feb; 45(2):268-75. PubMed ID: 11935159
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states.
    Kawachi H; Koike H; Kurihara H; Yaoita E; Orikasa M; Shia MA; Sakai T; Yamamoto T; Salant DJ; Shimizu F
    Kidney Int; 2000 May; 57(5):1949-61. PubMed ID: 10792613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension.
    Bonnet F; Cooper ME; Kawachi H; Allen TJ; Boner G; Cao Z
    Diabetologia; 2001 Jul; 44(7):874-7. PubMed ID: 11508272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glomerular abundance of nephrin and podocin in experimental nephrotic syndrome: different effects of antiproteinuric therapies.
    Nakhoul F; Ramadan R; Khankin E; Yaccob A; Kositch Z; Lewin M; Assady S; Abassi Z
    Am J Physiol Renal Physiol; 2005 Oct; 289(4):F880-90. PubMed ID: 15942045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in the expression of nephrin gene and protein in experimental diabetic nephropathy.
    Aaltonen P; Luimula P; Aström E; Palmen T; Grönholm T; Palojoki E; Jaakkola I; Ahola H; Tikkanen I; Holthöfer H
    Lab Invest; 2001 Sep; 81(9):1185-90. PubMed ID: 11555666
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unlike each drug alone, lisinopril if combined with avosentan promotes regression of renal lesions in experimental diabetes.
    Gagliardini E; Corna D; Zoja C; Sangalli F; Carrara F; Rossi M; Conti S; Rottoli D; Longaretti L; Remuzzi A; Remuzzi G; Benigni A
    Am J Physiol Renal Physiol; 2009 Nov; 297(5):F1448-56. PubMed ID: 19675181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of angiotensin II type 1 receptor blocker on 12-lipoxygenase activity and slit diaphragm protein expression in type 2 diabetic rat glomeruli.
    Xu HZ; Wang WN; Zhang YY; Cheng YL; Xu ZG
    J Nephrol; 2016 Dec; 29(6):775-782. PubMed ID: 27021232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.
    Benigni A; Tomasoni S; Gagliardini E; Zoja C; Grunkemeyer JA; Kalluri R; Remuzzi G
    J Am Soc Nephrol; 2001 May; 12(5):941-948. PubMed ID: 11316852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transforming growth factor-beta in human diabetic nephropathy: effects of ACE inhibition.
    Langham RG; Kelly DJ; Gow RM; Zhang Y; Cordonnier DJ; Pinel N; Zaoui P; Gilbert RE
    Diabetes Care; 2006 Dec; 29(12):2670-5. PubMed ID: 17130203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronically increased intrarenal angiotensin II causes nephropathy in an animal model of type 2 diabetes.
    Sharma R; Sharma M; Reddy S; Savin VJ; Nagaria AM; Wiegmann TB
    Front Biosci; 2006 Jan; 11():968-76. PubMed ID: 16146787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CIN85 Deficiency Prevents Nephrin Endocytosis and Proteinuria in Diabetes.
    Teng B; Schroder P; Müller-Deile J; Schenk H; Staggs L; Tossidou I; Dikic I; Haller H; Schiffer M
    Diabetes; 2016 Dec; 65(12):3667-3679. PubMed ID: 27531950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes, which translates into full renoprotection.
    Zoja C; Corna D; Gagliardini E; Conti S; Arnaboldi L; Benigni A; Remuzzi G
    Am J Physiol Renal Physiol; 2010 Nov; 299(5):F1203-11. PubMed ID: 20719975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria.
    Forbes JM; Bonnet F; Russo LM; Burns WC; Cao Z; Candido R; Kawachi H; Allen TJ; Cooper ME; Jerums G; Osicka TM
    J Hypertens; 2002 May; 20(5):985-92. PubMed ID: 12011660
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.